Medication Research Study for Body Dysmorphic Disorder
Some people who are very concerned about the way they look may suffer from a condition called Body Dysmorphic Disorder, or BDD. A person with BDD worries too much about the way they look and it interferes with their lives.
– Do you dislike the way any part(s) of your body (for example, your skin, hair, nose, eyes) look?
– Do you think about the way you look for more than one hour per day?
– Do you spend time checking on the way you look, or trying to hide or fix your appearance (for example, checking your looks in a mirror, comparing yourself to others, spending a lot of time fixing your appearance)?
If you answered 'yes' to any of these questions, you may be eligible to have a diagnostic evaluation and to take part in a research study at the Massachusetts General Hospital (MGH).
This research study will look at whether Lexapro, a marketed antidepressant medication, can help adults with BDD. This study will also look at whether people who do well on Lexapro continue to do well after stopping the drug. Lexapro is commonly used for BDD, but it is not currently approved by the FDA to treat BDD. (There are no FDA approved drugs to treat BDD).
The study involves 25 clinic visits over 9 months. During these visits, we will talk with you about how you are feeling and ask you to fill out some questionnaires about BDD symptoms, anxiety and mood.
If you would like to take part or would like more information about the study, please call the Body Dysmorphic Disorder Clinic at the Massachusetts General Hospital (MGH) at 877-4MGH-BDD (877-464-4233) or email BDD@partners.org.
Institution – MGH – Massachusetts General Hospital, Boston, MA
Principal Investigator – Sabine Wilhelm, PhD